Geodesic's NovaAtom-Lite Outperforms AlphaFold 3 on Drug Discovery Benchmark

Geodesic launched NovaAtom-Lite, an all-atom structure prediction model for drug discovery. NovaAtom-Lite achieved a success rate of 79.07% across 172 samples on the FoldBench antibody-antigen structure prediction benchmark. The model surpassed IsoDDE with 75.58% and AlphaFold 3 with 47.90% on the same benchmark. NovaAtom-Lite is available through the NovaDDE platform and the Geodesic API.